There is no FDA-approved 5-amino-1MQ dosage for humans. This guide reviews animal-study doses, oral vs. injectable research protocols, and safety cautions.
There is no FDA-approved 5-amino-1MQ dosage for humans, and no human clinical trial has established a safe or effective amount. Nearly all available dosing information comes from rodent studies and unverified online reports, which commonly range from 5 mg to 25 mg per day for injectable use. Anyone considering this research chemical should treat every dosing claim as experimental and consult a licensed healthcare professional first.
What Is 5-Amino-1MQ?
5-Amino-1MQ, also written as 5-amino-1-methylquinolinium, is a small-molecule inhibitor of nicotinamide N-methyltransferase, or NNMT. Researchers study NNMT because it influences how cells handle nicotinamide and may play a role in fat metabolism and energy balance.
The compound is sold online as a research chemical, not as a dietary supplement or prescription drug. Marketing language often focuses on fat loss and metabolic support, but those claims come almost entirely from animal models.
No published human trial has measured 5-amino-1MQ absorption, half-life, or side effects. That absence of data is the single most important fact for anyone researching how much to take.
5-Amino-1MQ Dosage in Animal Research
Most peer-reviewed work on 5-amino-1MQ has been done in mice. In those studies, researchers typically used about 5 mg per kilogram of body weight per day, often given orally through food, water, or gavage.
In mouse models of diet-induced obesity, that dose was linked to reduced fat mass and improved glucose tolerance. These are animal findings, not proven human outcomes.
Scaling an animal dose to a person is not as simple as multiplying by body weight. Differences in metabolism, absorption, and clearance mean a mouse milligram-per-kilogram dose does not translate directly to humans, and any conversion is speculative.
Oral vs. Subcutaneous Dosing: What People Report
Online communities describe a wide range of self-administered protocols. Many discussions about the 5-amino-1mq oral dosage mention 50 mg to 150 mg per day in capsules or liquid. Injectable users often describe the 5-amino-1mq dosage subcutaneous at 5 mg to 25 mg per day.
These figures are anecdotal and vary by vendor, body weight, and personal experimentation. No 5-amino-1mq dosage per day can be labeled standard, and individual response is unpredictable.
| Route | Commonly reported range | Frequency | Notes |
|---|---|---|---|
| Oral (capsule or liquid) | 50-150 mg per day | Once daily | Absorption is poorly characterized; stomach upset reported anecdotally |
| Subcutaneous injection | 5-25 mg per day | Once daily or split into two doses | Injection-site irritation possible; sterile technique required |
| Mouse research | About 5 mg/kg per day | Daily | Published in peer-reviewed metabolic studies |
Reconstitution and Injection Basics
Injectable 5-amino-1MQ is sold as a lyophilized powder in sealed vials. It must be mixed with bacteriostatic water or sterile saline before use, and 5-amino-1mq reconstitution and dosage are usually discussed together because concentration determines injection volume.
A common example: adding 2 mL of bacteriostatic water to a 10 mg vial produces a concentration of 5 mg per mL. A person aiming for a 5 mg dose would then draw 1 mL.
Community protocols often split one 10 mg vial into several smaller doses across the week. These protocols are not backed by human pharmacokinetic data.
Sterile technique, refrigerated storage, and safe sharps disposal are essential when handling any injectable research chemical. Many people search for a 5-amino-1mq dosage calculator, but online calculators simply repeat the same unverified community assumptions.
Safety, Legality, and Medical Guidance
5-Amino-1MQ is not approved by the FDA for human use. It is sold strictly for laboratory research, and marketing it as a supplement or weight-loss drug is illegal in the United States.
Because NNMT affects cellular metabolism, inhibiting it for months or years could have effects that no one has measured. Potential concerns include drug interactions, liver or kidney stress, and unknown consequences for pregnant or breastfeeding women.
No human safety data exists for 5-amino-1MQ, so any dose carries unknown short-term and long-term risk.
Anyone with a medical condition, anyone taking prescription medication, and anyone considering self-experimentation should speak with a licensed healthcare provider before using this compound.
The Bottom Line on 5-Amino-1MQ Dosing
There is no proven human 5-amino-1MQ dosage. Animal studies used roughly 5 mg/kg per day, while online reports range from 5 mg to 25 mg daily by injection or 50 mg to 150 mg orally.
Without clinical trials, no dose can be called safe, effective, or reliable. Readers should weigh the complete lack of human data against any promised benefit and seek professional medical advice.
Frequently Asked Questions
What is the typical 5-amino-1MQ dosage?
There is no established human dosage. Published mouse studies used about 5 mg per kg per day, while online reports describe 5-25 mg per day by subcutaneous injection or 50-150 mg per day orally. None of these figures come from controlled human trials.
Is 5-amino-1MQ safe to take?
5-Amino-1MQ is not FDA-approved for human use and has no published human safety data. Long-term effects, drug interactions, and organ toxicity are unknown. Anyone considering it should speak with a licensed healthcare professional first.
How do you reconstitute 5-amino-1MQ for injection?
Injectable 5-amino-1MQ arrives as a lyophilized powder that is mixed with bacteriostatic water or sterile saline. A typical example is 2 mL of water added to a 10 mg vial, which yields 5 mg per mL. Sterile technique and refrigerated storage are required.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.